Renaissance Technologies’s Baird Medical Investment Holdings BDMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.5K Buy
72,400
+17,029
+31% +$18.2K ﹤0.01% 3076
2026
Q2
$63.7K Buy
+55,371
New +$86K ﹤0.01% 3024

Other funds holding BDMD

Renaissance Technologies's BDMD Position: Q3 2026 in Review

Renaissance Technologies increased its Baird Medical Investment Holdings (BDMD) stake by 31% in Q3 2026, buying an estimated $18.2K and bringing the position to 72,400 shares worth $56.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

Renaissance Technologies first reported a position in BDMD in Q2 2026 and has held it in 2 quarters since. The position peaked at $63.7K in Q2 2026. 7 funds tracked by Wall St. Rank hold BDMD as of Q3 2026.

  • Renaissance Technologies held 72,400 shares of Baird Medical Investment Holdings worth $56.5K as of Q3 2026.
  • Renaissance Technologies bought 17,029 Baird Medical Investment Holdings shares in Q3 2026, an estimated $18.2K.
  • Baird Medical Investment Holdings made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #3076 holding.
  • Renaissance Technologies first reported a position in Baird Medical Investment Holdings in Q2 2026 and has held it in 2 quarters since.
  • Renaissance Technologies's Baird Medical Investment Holdings position peaked at $63.7K in Q2 2026.
  • 7 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.